Relmada Therapeutics
RLMD
RLMD
109 hedge funds and large institutions have $66.6M invested in Relmada Therapeutics in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 29 increasing their positions, 34 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
40% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 57
93% less capital invested
Capital invested by funds: $954M → $66.6M (-$887M)
100% less funds holding in top 10
Funds holding in top 10: 7 → 0 (-7)
Holders
109
Holding in Top 10
–
Calls
$7.39M
Puts
$1.67M
Top Buyers
| 1 | +$8.3M | |
| 2 | +$3.83M | |
| 3 | +$3.64M | |
| 4 |
Two Sigma Investments
New York
|
+$1.66M |
| 5 |
Walleye Capital
New York
|
+$1.65M |
Top Sellers
| 1 | -$88.2M | |
| 2 | -$76.9M | |
| 3 | -$74M | |
| 4 |
VA
VR Adviser
New York
|
-$56.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$31M |